- Report
- March 2025
- 85 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2023
- 146 Pages
Global
From €3211EUR$3,528USD£2,727GBP
€3777EUR$4,150USD£3,208GBP
- Report
- September 2024
- 129 Pages
United States
From €1387EUR$1,524USD£1,178GBP
€1981EUR$2,177USD£1,683GBP
- Report
- September 2024
- 240 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Book
- February 2024
- 4864 Pages
- Book
- February 2023
- 256 Pages
- Book
- March 2022
- 640 Pages
- Book
- February 2022
- 1056 Pages
- Book
- March 2021
- 208 Pages
- Book
- January 2020
- 504 Pages
- Book
- January 2020
- 504 Pages
- Book
- December 2019
- 2656 Pages
- Book
- December 2019
- 2656 Pages
- Book
- November 2019
- 416 Pages
- Book
- October 2019
- 192 Pages
- Book
- September 2019
- 280 Pages
- Book
- March 2019
- 552 Pages
- Book
- April 2016
- 4696 Pages
- Book
- January 2015
- 464 Pages

Psoriasis is a chronic skin condition that affects millions of people worldwide. It is characterized by red, scaly patches on the skin that can be itchy and painful. It is caused by an overactive immune system that triggers inflammation and rapid skin cell growth. Treatment for psoriasis typically involves topical medications, phototherapy, and systemic medications.
The psoriasis market is a subset of the larger dermatology market. It is a rapidly growing market, driven by the increasing prevalence of psoriasis and the development of new treatments. The market is highly competitive, with a number of companies offering treatments for psoriasis.
Some of the major companies in the psoriasis market include AbbVie, Amgen, Celgene, Janssen, Novartis, Pfizer, and UCB. These companies offer a range of treatments, including topical medications, phototherapy, and systemic medications. Show Less Read more